Santa Barbara, CA – According to filings with the U.S. Securities and Exchange Commission, Affinity Biosensors is raising $9,300,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kenneth Babcock played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Affinity Biosensors
Affinity Biosensors develops and manufactures award-winning analytical instruments for use in research, manufacturing, and life sciences. Instruments are based on the Companys exclusive Resonant Mass Measurement (RMM) technology. The sensor is a MEMS-fabricated sensor, enabling the measurement of mass in fluid, with femtogram resolution. The LifeScale instrument is the current state-of-the-art system to exploit Resonant Mass Measurement technology leading to new, unique and rapid techniques for the measurement and observation of microbe growth and response.

To learn more about Affinity Biosensors, visit http://www.lifescaleinstruments.com/

Contact:
Kenneth Babcock, Chief Executive Officer
805-960-5100
ken@affinitybio.com
https://www.linkedin.com/in/ken-babcock-695ab412/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved